Aerie: Aerie Pharmaceuticals gets grant for ocular disorder treatment using amino isoquinolinyl amide compounds
Discover how Aerie Pharmaceuticals' patented compounds target kinases and proteins to treat eye diseases, inflammation, and more. Explore the groundbreaking method for treating ocular disorders with Formula (I) compound.
Read full article »
Aerie is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies to treat open-angle glaucoma, ocular surface, and retinal diseases.
Read more